Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
Mohammed M. Aboudeif, Debuty Director of Strategic Planning Unit at King AbdulAziz University, shared a post on LinkedIn:
“Cerebral Venous Thrombosis (CVT): Think Early, Treat Decisively
Cerebral venous thrombosis is an uncommon but potentially devastating neurological emergency—and it can be easily missed because its presentation is often nonspecific.
Key clinical principles:
- Consider CVT in unexplained headache, seizures, focal neurological deficits, or raised intracranial pressure.
- MRI and MR venography (MRV) or CT venography (CTV) is essential for confirmation.
- Anticoagulation remains the cornerstone of acute treatment—even when venous intracranial hemorrhage is present.
- Identify and address underlying provoking factors and thrombophilia when appropriate.
- Recognize complications early: seizures, raised ICP, neurological deterioration, and venous infarction.
- In selected patients who deteriorate despite optimal anticoagulation, endovascular therapy may be considered in experienced centers.
Clinical pearl: A hemorrhagic venous infarction in a patient with suspected CVT is not, by itself, a reason to withhold anticoagulation.
Early recognition and appropriate anticoagulation, aggressive management of complications lead to better outcomes.”
1 Title: European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology
Authors: José M. Ferro, Marie-Germaine Bousser, Patrícia Canhão, Jonathan M. Coutinho, Isabelle Crassard, Francesco Dentali, Matteo Di Minno, Alberto Maino, Ida Martinelli, Florian Masuhr, Diana Aguiar de Sousa, Jan Stam.
Read the Full Article on European Stroke Journal
2 Title: European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology
Authors: J. M. Ferro, M.-G. Bousser, P. Canhão, J. M. Coutinho, I. Crassard, F. Dentali, M. di Minno, A. Maino, I. Martinelli, F. Masuhr, D. Aguiar de Sousa, J. Stam
Read the Full Article on European Journal of Neurology
Stay updated on all scientific advances Hemostasis Today.
-
Sep 8, 2026, 11:15Andreas Tridimas: Atherosclerosis Is Greyer Than We Admit
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome